Moderna gets further $472 million U.S. award for coronavirus vaccine development
As pharmaceutical execs sell shares worth millions, questions arise | CTV News
Science by press release': Sudden rise of vaccine developer Moderna rankles some in scientific establishment - ABC News
Moderna, Novavax developing combined COVID-19, flu shots | CBC News
Why Are Moderna Executives Selling Stock While Developing A Coronavirus Vaccine? : NPR
Moderna joins Association of the British Pharmaceutical Industry
Moderna considering creating an mRNA monkeypox vaccine amid growing demand for shots - ABC News
Moderna Gets OK to Start Larger Trial for a Coronavirus Vaccine - The New York Times
Moderna COVID-19 vaccine 93% effective, 'durable' at 6 months, company says
US government's Darpa probes Moderna's vaccine patents | Financial Times
Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older Adults - WSJ
FDA: Moderna COVID-19 Vaccine Is 94% Effective : Shots - Health News : NPR
Moderna to partner with ElevateBio on CRISPR research
Moderna executives have cashed out $89M in shares this year
Moderna, Inc. - Photos | Facebook
Moderna's Earnings, Revenue Fall on Fewer Covid Vaccine Sales - WSJ
Moderna's Coronavirus Vaccine is 94% Effective, Early Data Shows
Moderna Files for Largest-Ever Biotech IPO, Seeking to Raise $500M
Moderna bivalent Covid vaccine appears to work against omicron subvariants BA.4 and BA.5
Moderna's coronavirus vaccine is 94.5% effective, company says - National | Globalnews.ca
